Back to Search Start Over

Systemic inflammatory syndrome in children with FARSA deficiency.

Authors :
Charbit-Henrion F
Goguyer-Deschaumes R
Borensztajn K
Mirande M
Berthelet J
Rodrigues-Lima F
Khiat A
Frémond ML
Bader-Meunier B
Rodari MM
Seabra L
Rice GI
Legendre M
Drummond D
Berteloot L
Roux CJ
Boddaert N
Drabent P
Molina TJ
Lacaille F
Kossorotoff M
Cerf-Bensussan N
Parlato M
Hadchouel A
Source :
Clinical genetics [Clin Genet] 2022 May; Vol. 101 (5-6), pp. 552-558. Date of Electronic Publication: 2022 Feb 17.
Publication Year :
2022

Abstract

Variants in aminoacyl-tRNA synthetases (ARSs) genes are associated to a broad spectrum of human inherited diseases. Patients with defective PheRS, encoded by FARSA and FARSB, display brain abnormalities, interstitial lung disease and facial dysmorphism. We investigated four children from two unrelated consanguineous families carrying two missense homozygous variants in FARSA with significantly reduced PheRS-mediated aminoacylation activity. In addition to the core ARS-phenotype, all patients showed an inflammatory profile associated with autoimmunity and interferon score, a clinical feature not ascribed to PheRS-deficient patients to date. JAK inhibition improved lung disease in one patient. Our findings expand the genetic and clinical spectrum of FARSA-related disease.<br /> (© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1399-0004
Volume :
101
Issue :
5-6
Database :
MEDLINE
Journal :
Clinical genetics
Publication Type :
Academic Journal
Accession number :
35132614
Full Text :
https://doi.org/10.1111/cge.14120